Welcome to our dedicated page for Barrick Mining news (Ticker: B), a resource for investors and traders seeking the latest updates and insights on Barrick Mining stock.
Barrick Mining Corporation reports developments tied to its global gold and copper mining, exploration and development portfolio. Company news commonly covers operating and financial results, mine and project updates, technical and governance matters, and capital allocation actions for common shares that trade on the NYSE under B and on the TSX under ABX.
Recurring updates include quarterly results releases, dividend declarations, share repurchase authorizations, annual meeting materials and changes in executive or board oversight. Barrick also reports on its gold assets in North America and other mining jurisdictions, including disclosures connected to major mines, development projects, reserves, production, costs, cash flow and responsible mining obligations.
Metsera (NASDAQ: B) announced that its board has declared an amended proposal from Novo Nordisk a Superior Company Proposal under Metsera's merger agreement with Pfizer on Nov 4, 2025. The Novo Nordisk Amended Proposal values Metsera at up to $86.20 per share (~$10.0 billion) via a two-step structure: an immediate $62.20 per share cash payment plus non-voting preferred stock, followed by a dividend of $62.20, and a contingent value right (CVR) worth up to $24.00 per share upon regulatory and development milestones.
Metsera notified Pfizer, triggering a two-business-day period for Pfizer to propose adjustments under the Pfizer Merger Agreement; Pfizer previously revised its proposal to $60.00 upfront + up to $10.00 CVR.
Metsera (NASDAQ: B) announced its board has declared an unsolicited proposal from Novo Nordisk a Superior Company Proposal under Metsera's merger agreement with Pfizer. Novo Nordisk's two-step proposal would pay $56.50 per share in cash at signing, issue Novo non-voting preferred stock representing 50% of Metsera's share capital, then pay a CVR up to $21.25 per share upon milestones, valuing Metsera at up to $77.75 per share (~$9 billion).
The proposal represents an approximate 133% premium to Metsera's close on Sept 19, 2025. Metsera notified Pfizer, triggering a four-business-day period for Pfizer to propose adjustments; Pfizer disputes Metsera's right to deliver the notice. The Pfizer merger agreement remains in effect and Metsera's board reaffirmed its recommendation to approve the Pfizer transaction; no shareholder action is required now.
Barrick (NYSE:B) will report third quarter 2025 results on Monday, November 10, 2025, with the release timed for 6:00 AM ET. Management will host a live webcast presentation at 11:00 AM ET the same day followed by a Q&A with analysts. Presentation materials will be posted on the company website and a recording of the webcast will be available for replay later on November 10.
B (Barrick) agreed to sell its interests in the Tongon gold mine and related exploration permits in Côte d’Ivoire to Atlantic for up to $305 million. The consideration comprises $192 million cash (including a $23 million shareholder loan repayment within six months) plus up to $113 million in contingent cash payments tied to gold price over 2.5 years and resource conversions over 5 years. Proceeds will be used to strengthen Barrick’s balance sheet. Closing is expected in late 2025, subject to customary conditions including Government of Côte d’Ivoire approval.
Barrick Mining Corporation (NYSE:B) announced a significant leadership transition with the immediate appointment of Mark Hill as Group COO and Interim President & CEO, following Mark Bristow's departure after nearly seven years at the helm.
Hill, currently overseeing Barrick's Latam and Asia Pacific regions, brings 30 years of mining industry experience. Under Bristow's leadership since the 2019 Randgold merger, Barrick has returned $6.7 billion to shareholders and reduced net debt by $4 billion. The Board's Search Committee, led by Brett Harvey, has initiated a search for a permanent CEO with support from a leading executive search firm.
Barrick Mining (NYSE:B) has announced that its Fourmile project in Nevada is emerging as one of the century's most significant gold discoveries. The updated preliminary economic assessment (PEA) reveals potential for annual gold production of 600-750,000 ounces at mining rates of 1.5-1.8Mt per year.
The project boasts exceptional characteristics including high-grade resources of 3.6Mt @ 11.8g/t for 1.4Moz (M&I) and 14Mt @ 14.1g/t for 6.4Moz (Inferred), with exploration upside potential of 32-34Mt @ 15-16g/t. The project's preliminary economics indicate a mine life exceeding 25 years with projected AISC of $650-750/oz and estimated project capital of $1.5-1.7 billion.
Barrick Mining (NYSE:B) has announced the sale of its Hemlo Gold Mine in Canada to Carcetti Capital Corp. (to be renamed Hemlo Mining Corp.) for up to $1.09 billion. The deal structure includes $875 million in cash, $50 million in HMC shares, and potential additional payments of up to $165 million linked to production and gold prices starting January 2027.
HMC is led by experienced mining executive Robert Quartermain and backed by Wheaton Precious Metals and Orion Mine Finance Management. The transaction, expected to close in Q4 2025, is part of Barrick's strategy to focus on its Tier One gold and copper portfolio, with total proceeds from non-core asset sales expected to exceed $2 billion this year.
Integrum AB (INTEG B) unveiled its new global marketing strategy at the AOPA National Assembly in Orlando, introducing BondedMatrix™, a term describing the OPRA™ Implant System's unique capability to integrate soft tissue and bone. The strategy aims to better communicate the system's distinct advantages in bone-anchored prosthetics.
The OPRA™ Implant System, invented by Dr. Rickard Brånemark, has been refined since 1990 and has been used in over 1,000 implants worldwide. BondedMatrix™ specifically refers to the biologically integrated barrier connecting skin and bone at the penetration site, a unique feature achieved through OPRA's surgical technique and implant design.
Barrick Mining (NYSE:B) has appointed former Shell CEO Ben van Beurden as Lead Independent Director, succeeding Brett Harvey who held the position since 2013. Van Beurden, who joined Barrick's Board in May 2025, brings nearly four decades of experience in energy and natural resources sectors.
During his tenure at Shell, van Beurden led the company's transformation from an oil-focused business to a diversified energy leader. He currently serves as a senior advisor at KKR, board member at Mercedes-Benz Group AG, and Chairman of Clariant. Brett Harvey, who has been on Barrick's board since 2005, will continue as a board member.
Barrick Mining (NYSE:B) reported strong Q2 2025 results with significant improvements across key metrics. Net earnings per share reached $0.47, while operating cash flow for H1 2025 increased 32% year-over-year to $2.5 billion. Free cash flow surged 107% to $770 million.
Production showed notable growth with Q2 gold output up 5% and copper production rising 34% compared to Q1. Nevada Gold Mines led with an 11% production increase, while Pueblo Viejo saw a 28% boost. The company declared a $0.15 dividend and repurchased $268 million in shares during Q2.
Key growth projects remain on track, including Reko Diq's development and Fourmile's exploration program, which could potentially double existing resources by year-end. The company maintains strong sustainability performance with a 50% reduction in lost time injuries and continues advancing responsible closure initiatives.